LCTX Lineage Cell Therapeutics, Inc. BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Lineage Cell Therapeutics (LCTX) Stock: Buy, Sell, or Hold?

$0.82
-0.02 (-2.21%) ▼
5d: -17.2% 30d: -13.82% 90d: -24.07%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (95%)
Quality Score
57/100
Position
OVERSOLD
30-Day Fair Range
$0.90 – $1.05
Position: OVERSOLD
Forward P/E & Valuation
-7.5x
Next 12M consensus est.
Wall Street Target
$5.50
+570.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.77 / $1.13
Trend: Correction / Pullback
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: LCTX is down 17.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When LCTX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: LCTX is currently trading at $0.82, which is considered oversold relative to its 30-day fair value range of $0.90 to $1.05.

Technical Outlook: Technically, LCTX is showing correction / pullback momentum. Immediate support is located at $0.77, while resistance sits at $1.13.

Market Sentiment: LCTX scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+570.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.90 - $1.05
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 94.7%

Trading Range & Key Levels

30-Day Trading Range $0.90 - $1.05
Current vs Trading Range OVERSOLD
Support Level $0.77
Resistance Level $1.13
Current Trend Correction / Pullback
Technical data as of Nov 18, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKDOWN
Days in Phase: 6d (66% conf)
30D Insider Cluster Signal CLUSTER BUY
30D Insider Buyers: 3 insiders ($74,198)
30D Net Insider Flow: +$74,198

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (63/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 570.7% below Wall St target ($5.50)
  • BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
  • WARNING: Recommendation downgraded due to -17.2% 5-day decline - wait for stabilization

Fundamental Context

Forward P/E (Next Year Est.) -7.45
Wall Street Target $5.50 (+570.7%)
Revenue Growth (YoY) -61.0%
Profit Margin 16.2%
Share LCTX Analysis

Share this live LCTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (LCTX)

Bullish 5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 18, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages express bullish sentiment towards $LCTX, drawing parallels between its current situation and that of $SLS, which saw significant price growth after positive results and FDA approval.
Key Retail Themes: Positive results leading to price growth FDA approval
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 19, 2026 5:06 PM ET
Data refreshes hourly during market hours. Next update: 6:06 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for LCTX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 41 HOLD
ARGX
argenx NV ADR
STRONG BUY
24 analysts
$1147 43 HOLD
CLYM
Climb Bio Inc
STRONG BUY
16 analysts
$28 53 HOLD
SYRE
Spyre Therapeutics Inc.
STRONG BUY
18 analysts
$124 47 HOLD
DNTH
Dianthus Therapeutics In…
STRONG BUY
18 analysts
$139 36 SELL
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals